|
|
 |
BENZETHONIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADASUVE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADVAIR HFA Drug Profile, 2024 |
$399.00 |
|
$798.00 |
|
|
 |
AKEEGA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMVUTTRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|